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Schizophrenia is a severe and highly heritable psychiat-
ric disorder affecting approximately 1% of the popula-
tion. Genome-wide association studies have identified 108 
independent genetic loci with genome-wide significance 
but their functional importance has yet to be elucidated. 
Here, we develop a novel strategy based on network analy-
sis of protein–protein interactions (PPI) to infer biologi-
cal function associated with variants most strongly linked 
to illness risk. We show that the schizophrenia loci are 
strongly linked to synaptic transmission (PFWE < .001) and 
ion transmembrane transport (PFWE = .03), but not to onto-
logical categories previously found to be shared across psy-
chiatric illnesses. We demonstrate that brain expression of 
risk-linked genes within the identified processes is strongly 
modulated during birth and identify a set of synaptic genes 
consistently changed across multiple brain regions of adult 
schizophrenia patients. These results suggest synaptic 
function as a developmentally determined schizophrenia 
process supported by the illness’s most associated genetic 
variants and their PPI networks. The implicated genes may 
be valuable targets for mechanistic experiments and future 
drug development approaches.
Key words:  genetics/pathway analysis/functional 
analysis/GWAS
Introduction
Schizophrenia is a severe and heritable psychiatric disor-
der with a lifetime risk of approximately 1%. Substantial 
genetic risk is conferred by a large number of common 
alleles with small effect sizes.1–5 The most recent large 
scale association study of about 150 000 individuals has 
identified 108 independent genetic loci linked to the dis-
order with genome-wide significance.5 However, the infer-
ence of affected biological pathways is a bottleneck for 
understanding their etiological relevance. Commonly 
used functional analysis approaches explore pathways for 
enrichment of illness-associated variants at a genome-wide 
level.6,7 Such analysis has recently been performed across 
psychiatric illnesses and has identified links to histone 
methylation, immune pathways and largely schizophrenia 
specific associations in synaptic pathways.6 However, the 
interpretation of etiological mechanisms and the relation-
ship to illness risk is hampered by the large number and 
weak illness association of individual variants.
Therefore, functional analyses of variants with strong 
statistical support, such as genome-wide significance, 
would significantly aid interpretation but are challeng-
ing due to the small numbers of variants passing the 
significance threshold. For example, 2 commonly used 
enrichment methods did not find significantly enriched 
ontological categories among the 108 schizophrenia 
loci.5 In fact, functional analyses in the cancer field sug-
gest that sets of genes derived statistically do not inde-
pendently give insight into biological function.8 Rather, 
protein–protein interactions (PPI) were identified as a 
key element mapping genetic variation to biological pro-
cesses. PPI networks have previously been associated with 
schizophrenia risk genes but functional analysis of such 
networks has thus far been limited to conventional enrich-
ment analysis.9 For this application, inference of illness 
associated ontological categories depends on molecules 
indirectly linked to illness risk, ie, protein interaction 
partners of risk genes. Therefore, such analysis depends 
on the connectivity between the PPI network and the risk 
genes, which is not addressed by conventional enrichment 
methods. Risk genes with a high number of PPI partners 
within the same ontological category may lead to an over-
estimation of this category’s importance in relation to dis-
ease risk. Vice versa, such effects may reduce the power of 
identifying illness associations for other categories.
Building on substantial work by the Psychiatrics 
Genomics Consortium (PGC) and the consortium 
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behind the BrainSpan atlas, we have developed a novel 
approach to infer risk associated ontological categories 
from a network of PPI and GeneOntology information. 
We aimed to (1) identify ontological categories linked to 
the 108 schizophrenia risk loci and to show that associa-
tions are not confounded by the connectivity between risk 
loci and the PPI network, (2) explore whether ontological 
categories previously linked to schizophrenia by genome-
wide enrichment analyses mapped to the 108 loci, and 
(3) explore gene expression within identified risk cat-
egories across developmental stages and in adult schizo-
phrenia patients. For the latter analyses, we investigated 
BrainSpan data comprising expression data across mul-
tiple brain areas from healthy donors from before birth 
until old age.10 Brain expression analyses in schizophrenia 
patients were based on post-mortem samples from BA9, 
BA10, BA46, the superior temporal cortex, the parietal 
cortex, the hippocampus and the associative striatum in 6 
independent datasets.11–15 Such analysis may increase our 
understanding of the genetic underpinning of schizo-
phrenia specific and shared biological risk mechanisms.
Methods
Network Construction
Analysis was based on a network incorporating PPI 
(BioGRID database vs 3.2.11616) and ontological category 
information from the Gene Ontology (mappings from 
08.03.2014, derived from R library org.Hs.eg.db, vs 3.0.0, 
including the categories “biological process,” “molecu-
lar function,” and “cellular component; figure 1a). Our 
approach builds on work performed by PGC, as we are 
specifically focusing on the 108 genome-wide significant 
schizophrenia risk loci and the gene mapping identified 
by this consortium. As performed by the Network and 
Pathway Analysis Subgroup of the PGC,6 we focused 
analysis on ontological categories linked to at least 10 
genes. Within the PPI network, only genes mapping to at 
least 1 ontological category were retained. The network 
was an unweighted, undirected graph with links repre-
senting either PPIs or ontological annotations. Further 
details on the construction of the network investigated 
here are described in the supplementary methods and a 
schematic overview of the procedure is shown in supple-
mentary figure  1. This study received ethical approval 
from the local ethics committee (2013-842R-MA).
Analysis of Risk-Locus Associated Biological Processes
To quantify the strength of association between onto-
logical categories and risk loci, we determined the over-
representation of links between proteins linked to a given 
ontological category and the schizophrenia risk loci. For a 
given category, we determined across all i risk loci the sum 
∑i(b/dRISK) where b is the observed number of links between 
the category’s associated proteins and a given risk locus 
and dRISK is the risk locus’s degree. The locus’s degree is the 
number of links between the gene it maps to and all inter-
action partners in the PPI network. A given locus’s degree 
is proportional to the expected number of links between 
the locus and the category’s proteins, which is ∑dPPI * dRISK / 
(2*m), where ∑dPPI is the sum of the degrees of all proteins 
linked to a given ontological category and m is the total 
number of links in the PPI network. This expected number 
is equal to c * dRISK, where c is a constant since network 
configuration of the proteins linked to a given category, 
as well as the total number of links in the network do not 
change throughout the procedures applied here.
Fig. 1. Overview of network based functional analysis. a) Schematic illustration of the network linking the PPI to ontological category 
information. b) Selection of the 44 loci mapping to single, unique genes with at least 1 link to the PPI network. c) Network illustration 
of the 2 significantly schizophrenia associated ontological categories “synaptic transmission” (GO:0007268) and “ion transmembrane 
transport” (GO:0034765). Nodes are colored depending on their predominant link to a given ontological category or its respectively 
associated proteins (red-colored proteins are shared between ontological categories and red-colored risk loci predominantly associated 
with such nodes).
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To estimate significance the overrepresentation estimate 
was compared against estimates obtained from (106) ran-
dom selections of the same number of genes from the PPI 
network. The frequency of estimates at least as high as that 
from the real schizophrenia loci was used as empirical P 
value and adjusted for the Family-Wise-Error-Rate using 
Bonferroni’s method. Statistical analyses were performed 
considering as risk loci those 44 that mapped to single 
genes (out of a total of 108 loci with genome wide sig-
nificance, figure 1b, supplementary tables S1 and S2) and 
whose gene product had at least 1 interaction partner in 
the PPI network. We explored whether schizophrenia asso-
ciated results were confounded by properties of the inves-
tigated network, by confounders reported in a previous 
enrichment analysis of GWAS data17 or by the selection of 
loci mapping to single genes. Also, we tested whether risk 
associated ontological categories were specific for schizo-
phrenia compared to rheumatoid arthritis (RA) and pros-
tate cancer (PC) (supplementary methods). Analyses were 
performed using R (http://cran.r-project.org/).
Analysis of Gene Expression Across Developmental 
Stages
For analysis of brain expression across developmental 
stages, we build on work performed by the consortium 
behind the BrainSpan atlas. Data preprocessing was 
performed as previously described,10 data was quantile 
normalized using the R library limma, vs 3.22.1 and log2-
transformed. After filtering, the dataset comprised expres-
sion information on 16 brain regions from 47 donors. 
Data was aggregated into age-groups and brain regions 
as described previously6 and expression was represented 
by the respective mean levels within groupings. We evalu-
ated the change of expression throughout developmental 
stages using Spearman’s correlation analysis and due to 
the exploratory nature of this analysis, determined False 
Discovery Rate (FDR) adjusted P values according to 
the method of Benjamini and Hochberg.18
Preprocessing and Analysis of Gene Expression Data
For investigation of schizophrenia post-mortem brain 
expression, we utilized data from the GEO database and 
identified datasets by extensive keyword searches. Here, 
we focus on no-cerebellar datasets with at least 10 patient 
and control subjects per dataset. An overview of the 
datasets is shown in table 1. Expression was quantile nor-
malized and log2 transformed. Univariate case-control 
differences were determined using Wilcoxon tests and P 
values adjusted according to the method of Benjamini 
and Hochberg.18
Results
The network investigated here comprised 13 934 proteins, 
131 191 interactions between these, 2805 ontological cate-
gories and 161 900 links connecting ontological categories 
to proteins within the PPI network (figure 1a). Adjusting 
for the Family Wise Error Rate across all tested ontologi-
cal categories (n = 2417) linked to the schizophrenia risk 
loci through the PPI network, we found that “synaptic 
transmission” (GO:0007268, z = 8.98, Praw < 10
–6, PFWE < 
.001) and “ion transmembrane transport” (GO:0034765, 
z  =  9.77, Praw = 1.1·10
–5, PFWE  =  .03) were significantly 
linked to the schizophrenia risk loci. The networks rel-
evant for these associations (figure 1c) were linked to a 
total of 15 out of 44 risk loci via 38 different interac-
tion partners. Exploration of annotation quality of risk 
linked PPI partners showed that for GO:0007268, 87% of 
annotations were based on cited publications while 5% 
of annotations were based on computational methods. In 
contrast, for GO:0034765, 55% of genes were annotated 
computationally.
We aimed to exclude confounding due to the network’s 
configuration. For this, we compared schizophrenia loci 
to gene sets selected at random and found no significant 
associations (minimum P = .34) with several parameters 
detailed in the supplementary methods section. Similarly, 
illness associations were not affected by confounders 
known from functional analysis of GWAS data (mini-
mum P  =  .22, see supplementary methods).17 Analysis 
focused on loci that mapped to single genes, which may 
introduce bias if  such mapping is differentially associated 
with biological function. Therefore, we repeatedly selected 
44 genes containing at least 1 single nucleotide polymor-
phism (SNP) from genetic regions non-overlapping with 
Table 1. Overview Gene-Expression Datasets Used in This Study (SZ, Schizophrenia; HC, Healthy control)
Dataset Dataset Identifier Reference Brain Region No. of Subjects (SZ / HC)
I GSE17612 Maycox et al11 Anterior prefrontal cortex 
(Brodmann Area (BA) 10)
28 / 23
II GSE12679 Harris et al12 Prefrontal cortex (BA 9) 16 / 11
III GSE21935 Barnes et al13 Superior temporal cortex (BA22) 23 / 18
IV GSE53987 TA Lanz (presented at ACNP 2012) Hippocampus 15 / 18
Prefrontal cortex (BA46) 15 / 19
Associative striatum 18 / 18
V GSE35977 Chen et al14 Parietal cortex 49 / 49
VI GSE21138 Narayan et al15 Prefrontal cortex (BA46) 30 / 29
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any other genes using gene boundaries extended by 20kb 
as applied for annotation of the 108 risk loci.5 This also 
identified “synaptic transmission” (GO:0007268, Praw < 
10–6, PFWE < .001) and “ion transmembrane transport” 
(GO:0034765, Praw = 8.0·10
–6, PFWE = .02), as well as “reg-
ulation of long-term synaptic plasticity” (GO:0048169; 
Praw  =  1.2·10
–5, PFWE  =  .03) and “positive regulation of 
synaptic transmission” (GO:0050806; Praw = 10
–6, PFWE = 
.002) as significantly schizophrenia associated.
Associations of Ontological Categories Previously 
Linked to Schizophrenia
We explored potential associations between schizophre-
nia risk loci and ontological categories previously impli-
cated by the PGC cross-disorder working group. Of the 5 
categories most strongly associated with schizophrenia in 
a GWAS enrichment meta-analysis,6 4 had at least 10 links 
to the PPI network. The 2 ontological categories with the 
highest enrichment also showed significant associations 
to schizophrenia risk loci through the PPI network. These 
were “postsynaptic density” (GO:0014069; nominal 
P = .02) and “postsynaptic membrane” (GO:0045211; 
nominal P < .001). In contrast, the other 2 ontological 
categories (“dendritic spine,” GO:0043197, P = .66) and 
“histone H3-K4 methylation” (GO:0051568, P  =  .62), 
which was the most significantly enriched category across 
5 psychiatric disorders, showed no significant associations 
in the present study. Similarly, calcium channel activity 
(GO:0005262), the most significant ontological category 
implicated by SNP-based meta-analysis GWAS across 5 
psychiatric illnesses19 showed only a trend towards a sig-
nificant association (P = .08).
Analysis of Disease Specificity and Positive Control
We aimed to assess the specificity of the identified schizo-
phrenia associations, in particular to explore potential 
methodological bias that could lead to identification of 
the same risk associated ontological categories across dif-
ferent illnesses without strong genetic overlap. Therefore, 
we performed the same analysis on 25 and 41 risk SNPs 
linked to RA and PC, respectively. For both sets of 
risk genes, no significant associations were found. The 
ontological categories most strongly associated with 
PC and RA were “DNA-dependent ATPase activity” 
(GO:0008094, Praw  =  4.1·10
–5, PFWE  =  .08) and “T cell 
costimulation” (GO:0031295, Praw = 2.1·10
–4, PFWE = .42), 
respectively.
As positive control, we applied our method on GWAS 
results investigating the polygenic basis of dyslipidemia 
in over 19 000 subjects.20 Thirty loci have been found to 
be associated with quantitative molecular traits of dys-
lipidemia and cumulative allelic dosages of risk alleles 
at these loci were associated in a stepwise fashion with 
lipoprotein concentrations (decrease for high-density 
lipoprotein [HDL] cholesterol and increase for low-den-
sity lipoprotein (LDL) cholesterol and triglycerides).20 
Consistent with this, genome-wide enrichment analysis 
has found numerous associations with relevant lipid and 
lipoprotein pathways.17 To annotate a given locus, we use 
the gene in closest physical proximity to the index SNP or 
(if  available) the gene within 500kb whose expression has 
been found to be most strongly modulated by the index 
SNP20 (supplementary table S3). After correction for the 
family-wise error rate across 1838 ontological categories, 
we found significant associations with “LDL particle 
receptor binding” (GO:0050750, Praw = 7.0·10
–6, PFWE = 
.01) and “LDL particle” (GO:0034362, Praw  =  1.5·10
–5, 
PFWE = .03). Correcting for the FDR identified associa-
tions with 25 ontological categories with FDR < 0.05 
that were predominantly associated with lipid and lipo-
protein pathways (supplementary table S4). For added 
confirmation, we used only loci where a single gene was 
linked to the locus or the index SNP modulated expres-
sion of only 1 gene within 500kb. Using the resulting 12 
genes and the 1333 linked ontological categories yielded 
very similar results (supplementary table S4).
Developmental Trajectory of Synaptic Gene Expression
To investigate the potential neurodevelopmental role of 
the identified ontological categories, we examined in dif-
ferent developmental time-points and brain regions the 
expression of 36 of the 38 interaction partners linked to 
schizophrenia risk loci through the PPI network using the 
BrainSpan dataset (no data was available for GRIP1 and 
GNG10).10 This dataset contains expression data from 16 
brain regions in over 50 brains acquired across the human 
lifespan. We found that 22 of the investigated genes had 
a significant change in expression patterns across time 
(PFDR < .05, figure  2). Since expression appeared to be 
modulated most by birth, we split regional analyses con-
sidering separately samples taken before and after birth. 
This showed that after birth expression significantly 
increased with some regional specificity for neocortical 
regions.
Expression Analysis of Synaptic Genes
To explore potential expression differences of genes part 
of the 2 ontological categories, we used 6 gene expres-
sion datasets from post mortem brains of schizophrenia 
patients and controls (table 1). Using all genes part of the 
2 ontological categories, (total n  =  333–450, depending 
on the dataset) we found significant differences between 
schizophrenia patients and controls (FDR < .05) for 55 
and 4 genes in the hippocampus and prefrontal cortex of 
dataset IV, respectively, for 22 genes in the parietal cortex 
(dataset V) and 5 genes in the prefrontal cortex of dataset 
VI. Figure 3 shows the overlap between the identified gene 
sets and highlights the shared schizophrenia association 
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Fig. 2. Gene expression patterns throughout development stages and across brain regions. Genes were ordered using complete linkage 
hierarchical clustering on the Euclidean distance of their expression levels. Genes shown in bold show significant change throughout 
developmental stages (Spearman correlation, False Discovery Rate [FDR] < 0.05). Graphical layout adapted from ref.6
Fig. 3. Overlap of significant expression differences across datasets. Displayed genes showed expression changes with PFDR < .05. Arrows 
indicate whether expression was consistently increased (up arrow) or decreased (down arrow) across the datasets where a significant 
change in a given gene was observed.
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of the potassium channel genes KCNK1 and KCNS3 
across the hippocampus, the prefrontal and the parietal 
cortex. The relative overlap between gene sets with FDR 
< 0.05 was substantial. 20%, 100%, 55% and 60% of such 
genes in datasets IV (hippocampus), IV (BA46), V (pari-
etal cortex), and VI (BA46), respectively, overlapped with 
the significant gene sets in the respective other 3 datasets. 
We used permutation testing to show that even the lowest 
overlap of 20% was very unlikely to occur by chance, con-
sidering all pairwise comparisons between the 4 datasets 
described above (P < .001). All genes with FDR < 0.05 
are summarized in supplementary table S5.
Discussion
Here we showed that through consideration of the bio-
logical vicinity of risk genes, synaptic function emerges 
as a schizophrenia risk mechanism from genetic variants 
with the strongest risk association. This finding is con-
sistent with genome wide enrichment analysis,6 exome 
sequencing results,21,22 the effect of schizophrenia associ-
ated copy number variants (CNVs) on postsynaptic sig-
naling,23 as well as of psychiatric risk linked mutations on 
postsynaptic protein scaffolding.24 Consistent with this, 
postsynaptic function, a mostly schizophrenia specific 
pathway identified by enrichment analysis, was associated 
with schizophrenia risk loci. In contrast, histone methyla-
tion, the ontological category most strongly implicated 
across psychiatric illnesses, was not. This discrepancy 
may be due to the fact that our approach focuses on the 
most significant risk variants and differences compared 
to genome-wide analysis6 may suggest a divergence of 
biological risk mechanisms depending on the underly-
ing strength of risk association. Quantitative assessment 
of such divergence may provide interesting insights into 
biological risk mechanisms shared across and specific for 
individual disorders. Despite this, our results do not allow 
conclusions about illness specificity as synaptic processes 
may also be implicated by risk variants of other illnesses 
and their respective PPI networks. The identification of 
synaptic function as a schizophrenia risk process is fur-
ther consistent with numerous nongenetic studies.25–28 
For example, histopathological investigations have 
found reduced spine densities in multiple brain regions 
of schizophrenia patients that are thought to contrib-
ute to altered neural circuitry,29–33 as well as to reduced 
cortical and hippocampal volumes found in schizophre-
nia patients.26 Also, impaired synaptic neurotransmitter 
release and neurotransmission associated protein expres-
sion have been found in schizophrenia.34,35 A  synaptic 
pathology in schizophrenia is further consistent with 
findings in patients with encephalitis, where schizophre-
nia-like symptoms can be induced by IgG serum and 
CSF antibodies against N-methyl-D-aspartate glutamate 
receptors (NMDA-R).36 These antibodies selectively 
decrease NMDA-R clusters in postsynaptic dendrites37 
and have been found in serum of up to 10% of schizo-
phrenia patients.38–40 Interestingly, the induced symptom 
profile appears to depend on the intensity of the anti-
body effect on NMDA-R density, an effect similar to that 
observed for different doses of NMDA-R antagonists.38 
While low doses cause psychosis, anxiety, agitation, 
memory disturbance, decreased responsiveness to pain, 
and speech reduction, higher doses have been reported to 
induce unresponsiveness with catatonic features, dyskine-
sias, autonomic instability, and seizures.38,41–43
In the present study, expression analysis indicated a 
substantial brain expression change of risk-protein linked 
interaction partners during birth and some regional spec-
ificity of this effect for neocortical brain regions. We also 
found significant brain expression differences within the 
identified synaptic categories across multiple datasets and 
brain regions in adult schizophrenia patients. The stron-
gest differences were found in the hippocampus, the sub-
cortical region showing the most pronounced structural 
change in MRI investigations of schizophrenia patients.44 
Interestingly, the identified expression changes strongly 
overlapped across the hippocampus, parietal and pre-
frontal cortex, supporting synaptic alterations spanning 
across brain regions. Genes for the potassium channel 
proteins KCNK1 and KCNS3 showed consistent expres-
sion change across all of the aforementioned regions. 
Reduced expression of KCNS3 in prefrontal cortical par-
valbumin neurons in schizophrenia and has been linked 
to impaired γ-oscillations that are thought to underlie 
the cognitive impairments in schizophrenia.45 Reduced 
KCNK1 expression in schizophrenia patients has also 
been detected in previous prefrontal cortex expression 
studies.46,47
The strong change of synaptic gene expression we 
observed during the perinatal period may suggest that 
this period is particularly susceptible for the manifesta-
tion of genetically determined alterations in synaptic pro-
cesses that may then persist into adulthood. However, it 
should be taken into account that the present study pro-
vides only indirect evidence since it does not directly link 
genetic risk to protein expression during the perinatal 
period, and does not take into account other potentially 
relevant factors, such as post-translational modification, 
enzyme activity, molecular trafficking or schizophrenia 
specific differences in PPIs. Post mortem and neuroimag-
ing findings have highlighted the etiological relevance of 
synaptic function and support the hypothesis of schizo-
phrenia being a disorder induced by developmental syn-
aptic disturbances that lead to reduced synaptic plasticity 
and connectivity.25,48 Future experiments will show how 
genetic variation in schizophrenia risk loci impacts on 
perinatal gene expression. Of particular interest are inter-
actions with environmental factors previously linked to 
schizophrenia risk, such as perinatal and obstetric com-
plications,49,50 season of birth51 or prenatal malnutrition.52 
Obstetric complications have already been hypothesized 
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to increase schizophrenia risk via premature synaptic 
pruning caused by fetal hypoxia.53 Similarly, even moder-
ate malnutrition that does not impact on the offspring’s 
birth weight, has been shown to impair synaptic plasticity 
in rats.54
Limitations
Our study has several limitations. Since the network 
method is novel, our results should be seen as preliminary 
and need to be validated in independent samples and 
using alternative computational approaches. A  limita-
tion is our focus on risk loci that mapped to single genes, 
which omits a substantial amount of disorder-associated 
genetic variability. Such selection may be a biased rep-
resentation of the schizophrenia risk architecture and 
although our results suggest that selection of loci map-
ping to single genes did not bias the identified ontological 
categories, we cannot exclude the possibility of residual 
bias. Future studies incorporating loci mapping to mul-
tiple genes may face the challenge that a higher gene 
number can impede inference of risk associated onto-
logical categories, as such loci lead to stronger chance 
associations. Another limitation is that the data used in 
this study were not acquired for the objectives pursued 
here. Exome or whole genome sequencing data would 
have been more suitable in particular for mapping risk 
variants to genes. Another limitation is that inference was 
based on the content of a PPI network, whose underly-
ing data mainly originated from nonpsychiatric research, 
which may have biased our results. A similar issue may 
affect ontological categories, since human annotations 
are known to be non-equally distributed across genes and 
this may reflect differences in research interest regarding 
the respective genes.55 Variants were selected based on a 
genome-wide significance threshold, which reduces the 
risk of false-positives but is not without limitations due 
its inability to account for factors such as study power or 
the number of likely true positives.56 Also, the current def-
inition of “risk locus” relates to physical regions contain-
ing SNPs correlated with each of the 128 schizophrenia 
associated index SNPs with r2 > .6 (or .5 in the case of the 
dyslipidemia GWAS analyses), which may miss etiologi-
cally relevant genes mapping to SNPs in lower linkage 
disequilibrium. We found no significant links between 
ontological categories and risk genes of PC or RA, which 
may suggest that due to the approximately 7-fold higher 
patient numbers used for determination of schizophre-
nia risk loci compared those of RA and the combination 
of PC risk loci across multiple independent GWAS stud-
ies, schizophrenia risk loci may currently be supported 
by higher statistical power and may therefore cover a 
higher portion of true positive associations. Also, analy-
sis of RA and PC was based on published gene anno-
tations, which may not sufficiently capture etiologically 
relevant genes. Annotation quality analysis highlighted 
that a large portion of risk linked PPI partners within the 
ontological category GO:0034765 was computationally 
generated, which has been associated with lower reliabil-
ity compared to annotation based on experimental evi-
dence.57 Finally, we did not observe significant differences 
in 2 prefrontal cortex datasets (BA 9 and 10), the supe-
rior temporal cortex (BA22) and the associative striatum. 
This may be due to regional specificity of the expression 
changes we identified across BA46, the hippocampus and 
the parietal cortex or due to the small sample numbers 
that make it difficult to detect more subtle changes.
Conclusions
Using a novel functional analysis method we have iden-
tified strong links between schizophrenia risk loci and 
synaptic function. In contrast to genome-wide analysis, 
this method allows identification of specific loci that 
mediate associations with a given risk mechanism and 
pinpoints sets of risk associated genes for further mecha-
nistic investigations. Our results support the importance 
of PPI networks to map genetic risk to biological func-
tion. The assessment of such biological vicinity of risk 
genes may be a fruitful avenue for future investigations of 
schizophrenia associations in other data modalities, such 
as neuroimaging or polygenic analyses. Here, we found 
that brain expression of genes within the identified pro-
cesses changes substantially during early development, 
consistent with the etiological hypothesis of developmen-
tally determined synaptic alterations in schizophrenia. 
Our results link such synaptic processes with a small set 
of genes with strong risk association that may provide 
the basis for mechanistic experiments and which may be 
valuable targets for future drug development approaches.
Supplementary Material
Supplementary material is available at http://schizophre-
niabulletin.oxfordjournals.org.
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